Basic Principles in Oncology Course

Application deadline closed.

Chairs: A. Eniu, CH – S.D. Qanadli, CH

ESO is proposing a comprehensive course for oncology trainees in Europe intended to bridge the gap in education between courses for students and ESO’s well-known Masterclasses. The course aims to provide orientation to the guiding principles of multidisciplinary oncological management and life as a modern oncologist.

Although some of the principles underlying oncology practice are similar to those in other branches of medicine, sub-specialisation has reduced the exposure of medical students and junior residents to oncological concepts and practice. New oncology trainees face a number of specific challenges. These include navigation of an extensive curriculum with no clear starting point, a rapidly evolving clinical landscape, and increasing clinical demands. During training, residents must also strategically plan their careers, manage any academic focus, and maintain a healthy work-life balance.

The course is divided into 2 parts:

Part 1: participants will be asked to view pre-recorded lectures which were recorded during the 1st edition of the course in Ljubljana, Slovenia in 2022 and will be made available on the e-Eso website.

Part 2: in-person event.

Learning Outcomes

• Update on basic principles in etiology and epidemiology
• Update on basic cancer genetics, staging and imaging
• Update on basic surgical oncology and pathology
• Update on basic radiology and chemotherapy
• Intro to paediatric oncology
• Intro to tumour board and patient issues: communication, supportive and palliative care
• Intro to clinical trials and paper appraisal

In collaboration with Hôpital Riviera-Chablais.

OFFICIAL LANGUAGE

The official language will be English. No translation will be available.

CME ACCREDITATION

Application for CME recognition will be submitted to the Accreditation Council of Oncology in Europe (ACOE). The American Medical Association (AMA) and the Accreditation Council for Continuous Medical Education (ACCME) designate this type of educational activity for a maximum of 1 AMA PRA category 1 credits per hour of activity.

     ESCO - The ESO College

Being selected to take part in this ESO Course is one of the ESO activities that gives participants eligibility to enroll in ESCO - the College of the European School of Oncology.
It also enables ESCO students to earn ESCO credits and therefore access more ESCO benefits.
Full and active participation in the Basic Principles in Oncology course earns participants 18 ESCO credits.
Visit www.ESCO.org for more information on how to join ESCO.

PARTICIPATION

Attendance is limited to 60 participants and admittance is by competitive application only. Priority will be given to applicants who have attended an ESO-ESMO course for medical students or the ESO-ESSO-ESTRO-SIOPe course for medical students.

Successful applicants are granted free registration.

Accommodation at a hotel in the Montreux area to the course venue for arrival on Thursday 25 April and departure on Sunday 28 April will be provided to participants not residing in the Rennaz area.

Participants will be given a travel card at the hotel so that they can reach Rennaz Hospital, the course venue by public transport.

ORGANISING SECRETARIAT

Corinne Hall
European School of Oncology (ESO)
Via Filippo Turati 29
20121 – Milan
ph +39 335 1814541
e-mail: chall@eso.net

Dolores Knupfer
European School of Oncology (ESO)
Via Vincenzo Vela, 6
6500 Bellinzona
ph +41 91 820 09 50
e-mail: dknupfer@eso.net

Matti Aapro, Clinique de Genolier, Genolier Cancer Center, Genolier, CH
Stefan Aebi, Lucerne Cantonal Hospital, Dept. of Medical Oncology, Lucerne, CH
Riccardo A. Audisio, Institute of Clinical Sciences, University of Göteborg, SE
Stefan Bielack, Klinikum Stuttgart - Olgahospital, Dept. of Pediatric Oncology, Hematology, Immunology Dpt., Stuttgart, DE
Christopher Booth, Queen's University, Dept. of Oncology, Kingston, ON, CA
Freddie Bray, International Agency for Research on Cancer, Section of Cancer Surveillance, Lyon, FR
Silvia Brotea-Mosoiu, Oncology Institute of Bucharest, Medical Oncology Dept., Bucharest, RO
Anastasia Constantinidou, Bank of Cyprus Oncology Centre and Medical School University of Cyprus, Dept. of Oncology, Nicosia, CY
Tanja Cufer, University of Ljubljana, Medical Faculty, Ljubljana, SI
Urania Dafni, National and Kapodistrian University of Athens, Public Health Dpt., Goudi-Athens, GR
Berardino De Bari, Neuchâtel Hospital Network, Dept. of Radiation Oncology, La Chaux-de-Fonds, CH
Filippo De Braud, Milan, IT
Alexandru Eniu, Riviera-Chablais Hospital, Medical Oncology, Rennaz, CH
Pierfrancesco Franco, University of Eastern Piedmont, Dept. of Translational Medicine, Novara, IT
Mary Gospodarowicz, Princess Margaret Cancer Centre - University of Toronto, Dept. of Radiation Oncology, Toronto, CA
Douglas Hanahan, ISREC- Swiss Institute for Experimental Cancer, Dept. of Life Sciences, Lausanne, CH
Assia Konsoulova, National Cancer Hospital, Medical Oncology Clinic, Sofia, BG
Fatjona Kraja, Mother Teresa University Hospital, Oncology Dept., Tirana, AL
Danny Kupka, Freiburger Spital, HFR Kantonsspital Freiburg, Department of Oncology, Freiburg, CH
Erika Matos, Institute of Oncology Ljubljana, Dept. of Medical Oncology, Ljubljana, SI
Asteria Nikolopoulou, Hopital Riviera Chablais, Dept. of Oncology, Rennaz, CH
Olivia Pagani, Hopital Riviera Chablais, Dept. of Oncology, Rennaz, CH
Giancarlo Pruneri, National Cancer Institute, IRCCS Foundation, Pathology Dpt., Milano, IT
Salah Qanadli, Riviera-Chablais Hospital, Rennaz, CH
Domen Ribnikar, Institute of Oncology Ljubljana, Medical Oncology Dpt., Ljubljana, SI
Emanuela Salati, Hopital Riviera Chablais, Dept. of Oncology, Rennaz, CH
Uta Schmidt-Strassburger, Ulm University, Learning and Teaching, Medical Faculty, Ulm, DE
Christos Sotiriou, Institut Jules Bordet, Breast Cancer Translational Research Laboratory J.C. Heuson, Brussels, BE
Ian Tannock, Princess Margaret Hospital, Dept of Oncology and Haematology, Toronto, CA
Luzia Travado, Champalimaud Foundation, Champalimaud Clinical and Research Center, Lisbon, PT
Sheila Unger, Genetica, Medical Genetics Department, Lausanne, CH
Khalil Zaman, CHUV - Centro Ospedaliero Universitario del Vaud, Oncology Dpt., Lausanne, CH

25 places are available as a free observer to this event for internes from the Riviera Chablais Hospital.

A further 25 places for medical students in their penultimate or final year of studies at the Universities of Lausanne or Geneva.

Accommodation will not be provided.

If you are interested to participate, please click on the tab above.

Registration deadline 15 April.